The most innovative biotech companies of 2026

The Most Innovative Companies in biotech reflect a year in which companies took big swings—delivering breakthrough treatments to the clinic, bringing groundbreaking tests to the public, and building out the tools to support future breakthroughs. eGenesis made headlines by transplanting genetically modified pig kidneys into humans—sustaining one patient for 271 days without dialysis, a record, with a second recipient still off dialysis since a June 2025 transplant—and scored FDA clearance for an expanded trial. Insilico Medicine backed up the promise of its AI drug design platform with Phase 2a data showing its lead therapeutic candidate, rentosertib, stabilized lung function in IPF patients. Replicate and Strand Therapeutics demonstrated the potential of next-generation RNA-based technologies for more durable vaccines and targeted cancer treatments, and Faeth Therapeutics saw positive results in a phase 1b study of its novel tumor-starving drug Piktor. It was also a big year for preven